MBX Biosciences appoints Peter Radovich to board of directors
MBX•MBX Biosciences appointed Peter Radovich, Mirum Pharmaceuticals’ president and chief operating officer, to its board in October 2026. Jeff Held became MBX’s chief legal officer in September 2026.
1. Leadership appointments
MBX Biosciences appointed Peter Radovich, Mirum Pharmaceuticals’ president and chief operating officer, to its board in October 2026. Jeff Held became chief legal officer in September 2026, bringing more than 30 years of experience, including leadership roles at Zenas BioPharma and Deciphera Pharmaceuticals.
